ORBIMED ADVISORS LLC

Position in FBRX — Forte Biosciences, Inc.

CIK 1055951 New York, NY

Position in FBRX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$33,526,231

+$2,525,097 QoQ

Shares Held

1,577,705

+31.8% QoQ

Ownership

7.43%

of shares outstanding

% of Portfolio

0.66%

of 13F equity value

Holder Rank

of 85 holders

Holding Since

Jun 2020

11 quarters on record

Voting authority Sole 80% Shared 0% None 20%

Healthcare · as of Jun 30, 2026

ORBIMED ADVISORS LLC holds $3,639,640,835 across 90 Biotechnology names. FBRX ranks #30 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EWTX	Edgewise Therapeutics, Inc.	15,518,492	$630,516,329
2	ELVN	Enliven Therapeutics, Inc.	6,776,632	$343,914,074
3	MBX	MBX Biosciences, Inc.	3,428,736	$189,266,227
4	GPCR	Structure Therapeutics Inc.	2,209,400	$118,578,498
5	SION	Sionna Therapeutics, Inc.	2,555,877	$112,433,029
6	CRVS	Corvus Pharmaceuticals, Inc.	7,165,006	$107,045,189
7	AVBP	ArriVent BioPharma, Inc.	3,027,328	$105,169,374
8	ARGX	Argenx SE	92,880	$86,171,277

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$26,880,825	1,264,980	—	Shares	Sole	2026-08-14
2026-06-30	$33,526,231	1,577,705	+31.8%	Shares	Defined	2026-08-14
2026-03-31	$31,001,134	1,196,955	0.0%	Shares	Defined	2026-05-15
2025-12-31	$32,640,962	1,196,955	0.0%	Shares	Defined	2026-02-17
2025-09-30	$17,954,325	1,196,955	0.0%	Shares	Defined	2025-11-14
2025-06-30	$15,476,628	1,196,955	+101.8%	Shares	Defined	2025-08-14
2025-03-31	$4,602,362	593,088	-1.2%	Shares	Defined	2025-05-15
2024-12-31	$13,626,000	600,000	+275.8%	Shares	Defined	2025-02-14
2021-03-31	$5,471,685	159,664	+73.2%	Shares	Defined	2021-05-17
2020-12-31	$3,357,002	92,200	-72.9%	Shares	Defined	2021-02-16
2020-09-30	$16,516,684	340,480	-64.2%	Shares	Defined	2020-11-16
2020-06-30	$13,855,607	950,316	—	Shares	Defined	2020-08-14
No filing history on record for this holder in this stock.